NORTH AMERICA OPIOIDS DRUG MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA OPIOIDS DRUG MARKET FORECAST 2019-2027

NORTH AMERICA OPIOIDS DRUG MARKET FORECAST 2019-2027

Opioids are narcotic drugs that create morphine-like effects and are mostly indicated for pain management. The opioids drug market supplies these narcotics mainly for post-surgical pains. The market growth can be reasoned by many factors like the growing prevalence of cancer, high demand for pain therapeutics in the treatment of chronic pain, etc. The North America opioids drug market is expected to contribute the majority of share X% by 2027. Also, the market is growing steadily at 2.29% CAGR during the forecast tenure of 2019-2027.

NORTH AMERICA OPIOIDS DRUG MARKET FORECAST 2019-2027

North America Opioids Drug Market by Products (Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol and Other Products), by Application (Pain Relief), & by Geography.

Request free sample

Opioids are narcotic drugs that create morphine-like effects and are mostly indicated for pain management. The opioids drug market supplies these narcotics mainly for post-surgical pains. The market growth can be reasoned by many factors like the growing prevalence of cancer, high demand for pain therapeutics in the treatment of chronic pain, etc. The North America opioids drug market is expected to contribute the majority of share X% by 2027. Also, the market is growing steadily at 2.29% CAGR during the forecast tenure of 2019-2027.

The drug has several side effects such as mental fog, drowsiness, constipation and nausea and also, there is a high risk of drug-dependency and addiction to happen. Opioid addiction, abuse and overdose are serious worldwide public health concerns that are hindering the market growth especially in the North American region where the market is already opioid dependent. The countries of the United States and Canada have the major contributing economies that comprise the North American regional market. Out of them, the U.S. holds the largest share for the regional market for opioids drugs because the market is heavily complimented by the rigorous implementation of clinical guidelines and policies against opioid misuse. There have been growth initiatives from the Canada government against the opioid crisis and rising incidence of opioid abuse and addiction in the country; these factors are hard-pressing the Canada opioids drugs market to be the fastest growing one in North America by 2027.

There are many establishments which have profited the most in the North America opioids drug market, some of them are mentioned here: Daiichi Sankyo, Inc., Acura Pharmaceuticals, Inc., BioDelivery Sciences International, Inc., Cipher Pharmaceuticals, Inc., Collegium Pharmaceutical, Inc., Egalet Corp., Hikma Pharmaceuticals PLC, Indivior, Inc., Insys Therapeutics, Inc., Allergan PLC, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Lannett Co. Inc., Mylan NV, Pfizer, Inc., Purdue Pharma LP, Sanofi-Aventis S.A., Sun Pharmaceutical Industries Limited (Sun Pharma), Lupin Ltd. and Teva Pharmaceutical Industries Ltd.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • OXYCODONE HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCT
      • ANESTHESIA IS THE MAJORLY USED APPLICATION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • INCREASING ROAD ACCIDENTS AND SURGICAL PROCEDURES
      • ESCALATING PALLIATIVE CARE FOR PATIENTS SUFFERING INTENSELY
      • USAGE OF ABUSE DETERRENT FORMULATIONS TO RESTRICT THE OPIOID ABUSE
      • GROWING OCCURRENCE OF CHRONIC PAIN
    • MARKET RESTRAINTS
      • MISUSE OF OPIOIDS
      • STRINGENT REGULATORY FRAMEWORK
    • MARKET OPPORTUNITIES
      • INCREASING USE OF EXTENDED-RELEASE OPIOID FORMULATIONS
      • WIDE RANGE OF APPLICATIONS OF OPIOIDS IN THE THERAPEUTIC MANAGEMENT
    • MARKET CHALLENGES
      • INCREASING NUMBER OF LAWSUITS CASES AGAINST OPIOIDS MANUFACTURERS
      • RISING OCCURRENCE OF DEATHS RELATED TO OPIOID OVERDOSE
  1. MARKET BY PRODUCTS
    • BUPRENORPHINE
    • FENTANYL
    • HYDROCODONE
    • MORPHINE
    • OXYCODONE
    • TRAMADOL
    • OTHER PRODUCTS
  2. MARKET BY APPLICATION
    • PAIN RELIEF
      • CANCER PAIN
      • POSTOPERATIVE PAIN MANAGEMENT
      • LOW BACK PAIN
      • ORTHOPEDIC
      • NEUROPATHIC
      • FIBROMYALGIA
    • ANESTHESIA
    • COUGH SUPPRESSION
    • DIARRHEA SUPPRESSION
    • DEADDICTION
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • REGULATORY FRAMEWORK
    • PIPELINE ANALYSIS
    • INDUSTRY EVENTS IN OPIOID DRUGS MARKET
    • TECHNOLOGIES ADVANCEMENT
    • OPPORTUNITY MATRIX
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • ACURA PHARMACEUTICALS, INC.
      • ALLERGAN PLC
      • BIODELIVERY SCIENCES INTERNATIONAL, INC.
      • CIPHER PHARMACEUTICALS INC.
      • COLLEGIUM PHARMACEUTICAL, INC.
      • DAIICHI SANKYO, INC.
      • EGALET CORP.
      • HIKMA PHARMACEUTICALS PLC
      • INDIVIOR INC.
      • INSYS THERAPEUTICS, INC.
      • JANSSEN PHARMACEUTICALS, INC.
      • JOHNSON & JOHNSON
      • LANNETT CO. INC.
      • LUPIN LTD.
      • MYLAN NV
      • PFIZER INC.
      • PURDUE PHARMA LP
      • SANOFI-AVENTIS S.A.
      • SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
      • TEVA PHARMACEUTICAL INDUSTRIES LTD.

TABLE LIST

TABLE 1       NORTH AMERICA OPIOIDS DRUG MARKET 2019-2027 ($ MILLION)

TABLE 2       ANESTHETIC EFFECTS OF DRUGS AT DIFFERENT OPIOID RECEPTORS

TABLE 3       FDA APPROVED OPIOIDS WITH ADF LABELLING

TABLE 4       NUMBER OF LAWSUITS SETTLED BY OPIOIDS MANUFACTURING COMPANIES AND PHARMACIES 2015–2027

TABLE 5       NORTH AMERICA OPIOIDS DRUGS MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 6       NORTH AMERICA BUPRENORPHINE MARKET 2019-2027 ($ MILLION)

TABLE 7       NORTH AMERICA FENTANYL MARKET 2019-2027 ($ MILLION)

TABLE 8       NORTH AMERICA HYDROCODONE MARKET 2019-2027 ($ MILLION)

TABLE 9       NORTH AMERICA MORPHINE MARKET 2019-2027 ($ MILLION)

TABLE 10     NORTH AMERICA OXYCODONE MARKET 2019-2027 ($ MILLION)

TABLE 11     NORTH AMERICA TRAMADOL MARKET 2019-2027 ($ MILLION)

TABLE 12     NORTH AMERICA OTHER PRODUCTS MARKET 2019-2027 ($ MILLION)

TABLE 13     NORTH AMERICA OPIOIDS DRUGS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 14     NORTH AMERICA OPIOIDS DRUGS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 15     NORTH AMERICA PAIN RELIEF MARKET 2019-2027 ($ MILLION)

TABLE 16     NORTH AMERICA PAIN RELIEF MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 17     NORTH AMERICA CANCER PAIN MARKET 2019-2027 ($ MILLION)

TABLE 18     NORTH AMERICA POSTOPERATIVE PAIN MANAGEMENT MARKET 2019-2027 ($ MILLION)

TABLE 19     NORTH AMERICA LOW BACK PAIN MARKET 2019-2027 ($ MILLION)

TABLE 20     NORTH AMERICA ORTHOPEDIC MARKET 2019-2027 ($ MILLION)

TABLE 21     NORTH AMERICA NEUROPATHIC MARKET 2019-2027 ($ MILLION)

TABLE 22     NORTH AMERICA FIBROMYALGIA MARKET 2019-2027 ($ MILLION)

TABLE 23     NORTH AMERICA ANESTHESIA MARKET 2019-2027 ($ MILLION)

TABLE 24     NORTH AMERICA COUGH SUPPRESSION MARKET 2019-2027 ($ MILLION)

TABLE 25     NORTH AMERICA DIARRHEA SUPPRESSION MARKET 2019-2027 ($ MILLION)

TABLE 26     NORTH AMERICA DEADDICTION MARKET 2019-2027 ($ MILLION)

TABLE 27     LIST OF ER/LA OPIOID BRANDED DRUGS 2017

TABLE 28     LISTS OF ER/LA OPIOID GENERIC DRUGS 2017

TABLE 29     CDC GUIDELINES ON PRESCRIBING OPIOIDS

TABLE 30     PIPELINE ANALYSES OF OPIOID DRUGS

TABLE 31     NORTH AMERICA OPIOIDS DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)

 

FIGURE LIST

FIGURE 1     NORTH AMERICA OPIOIDS DRUG MARKET 2019-2027 ($ MILLION)

FIGURE 2     NUMBER OF DEATHS IN THE UNITED STATES DUE TO DRUG OVERDOSE 2010–2016

FIGURE 3     NORTH AMERICA OPIOIDS DRUGS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)

FIGURE 4     NORTH AMERICA OPIOIDS DRUGS MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE 5     PORTER’S FIVE FORCE MODEL

FIGURE 6     NORTH AMERICA OPIOIDS DRUGS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 7     THE UNITED STATES OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 8     NUMBER OF OPIOID PRESCRIPTIONS DISPENSED IN THE UNITED STATES 2015-2017 (MILLIONS)

FIGURE 9     NUMBER OF DRUG OVERDOSE DEATHS IN THE UNITED STATES 2010-2016

FIGURE 10   CANADA OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 11   OPIOIDS MARKET POSITION ANALYSIS 2017

  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY PRODUCTS
    • BUPRENORPHINE
    • FENTANYL
    • HYDROCODONE
    • MORPHINE
    • OXYCODONE
    • TRAMADOL
    • OTHER PRODUCTS
  2. MARKET BY APPLICATION
    • PAIN RELIEF
      • CANCER PAIN
      • POSTOPERATIVE PAIN MANAGEMENT
      • LOW BACK PAIN
      • ORTHOPEDIC
      • NEUROPATHIC
      • FIBROMYALGIA
    • ANESTHESIA
    • COUGH SUPPRESSION
    • DIARRHEA SUPPRESSION
    • DEADDICTION

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now